Journal of Gastrointestinal Surgery

, Volume 18, Issue 10, pp 1760–1769

High Performing Whipple Patients: Factors Associated with Short Length of Stay after Open Pancreaticoduodenectomy

  • Grace C. Lee
  • Zhi Ven Fong
  • Cristina R. Ferrone
  • Sarah P. Thayer
  • Andrew L. Warshaw
  • Keith D. Lillemoe
  • Carlos Fernández-del Castillo
Original Article

Abstract

Introduction

Despite the decreasing mortality of pancreaticoduodenectomy (PD), it continues to be associated with prolonged length of postoperative hospital stay (LOS). This study aimed to determine factors that could predict short LOS after PD. Additionally, as preliminary data of minimally invasive PD emerges, we sought to determine the average LOS after open PD at a high-volume center to set a standard to which minimally invasive PD can be compared.

Methods

A total of 634 consecutive patients who underwent open PD between January 2007 and December 2012 at the Massachusetts General Hospital comprised the study cohort. “High performers” were defined as patients with postoperative LOS ≤5 days.

Results

Median LOS was 7 days. A total of 61 patients (9.6 %) had LOS ≤5 days and were deemed “high performing.” In multivariate logistic regression analysis, male gender (p = 0.032), neoadjuvant chemoradiation (p = 0.001), epidural success (p = 0.019), epidural duration ≤3 days (p = 0.001), lack of complications (p < 0.001), surgery on Thursday or Friday (p = 0.001), and discharge on Monday through Wednesday (p < 0.001) were independently associated with LOS ≤5 days. Readmission rate, time to readmission, and mortality were not different between the two groups. The proportion of patients with pancreatic ductal adenocarcinoma who went on to receive adjuvant therapy was no different if LOS was ≤5 or >5 days, but high performance was predictive of beginning therapy <8 weeks after surgery (p = 0.010).

Conclusion

In our experience, median LOS was 7 days, and early discharge (≤5 days) after open PD is safe and feasible in about 10 % of patients. These high performers are more likely to be male, have received neoadjuvant therapy, and had successful epidural analgesia. High performers with cancer are more likely to start chemotherapy <8 weeks after surgery. Minimally invasive PD should be compared to this high standard for median LOS, among other quality metrics, to justify its increased cost, operative duration, and learning curve.

Keywords

Length of stay Pancreaticoduodenectomy Cost Epidural analgesia Weekday 

References

  1. 1.
    Moses H, 3rd, Matheson DH, Dorsey ER, George BP, Sadoff D, Yoshimura S. The anatomy of health care in the United States. JAMA 2013;310:1947-63.PubMedCrossRefGoogle Scholar
  2. 2.
    Fong ZV, Ferrone CR, Thayer SP, Wargo JA, Sahora K, Seefeld KJ, Warshaw AL, Lillemoe KD, Hutter MM, Fernandez-Del Castillo C. Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?: a 10-year contemporary experience with 1,173 patients at the Massachusetts General Hospital. J Gastrointest Surg 2014;18:137-44.PubMedCrossRefGoogle Scholar
  3. 3.
    Teh SH, Diggs BS, Deveney CW, Sheppard BC. Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines. Arch Surg 2009;144:713-21.PubMedCrossRefGoogle Scholar
  4. 4.
    Schneider EB, Hyder O, Wolfgang CL, Dodson RM, Haider AH, Herman JM, Pawlik TM. Provider versus patient factors impacting hospital length of stay after pancreaticoduodenectomy. Surgery 2013;154:152-61.PubMedCrossRefGoogle Scholar
  5. 5.
    Balcom JH, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg 2001;136:391-8.PubMedCrossRefGoogle Scholar
  6. 6.
    Fernandez-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, Lillemoe KD, Warshaw AL. Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery 2012;152:S56-63.PubMedCrossRefGoogle Scholar
  7. 7.
    He J, Ahuja N, Makary MA, Cameron JL, Eckhauser FE, Choti MA, Hruban RH, Pawlik TM, Wolfgang CL. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford) 2014;16:83-90.CrossRefGoogle Scholar
  8. 8.
    Kennedy EP, Rosato EL, Sauter PK, Rosenberg LM, Doria C, Marino IR, Chojnacki KA, Berger AC, Yeo CJ. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution—the first step in multidisciplinary team building. J Am Coll Surg 2007;204:917-23.PubMedCrossRefGoogle Scholar
  9. 9.
    Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006;10:1199-210.PubMedCrossRefGoogle Scholar
  10. 10.
    Ho V, Aloia T. Hospital volume, surgeon volume, and patient costs for cancer surgery. Med Care 2008;46:718-25.PubMedCrossRefGoogle Scholar
  11. 11.
    Porter GA, Pisters PW, Mansyur C, Bisanz A, Reyna K, Stanford P, Lee JE, Evans DB. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 2000;7:484-9.PubMedCrossRefGoogle Scholar
  12. 12.
    Mesleh MG, Stauffer JA, Bowers SP, Asbun HJ. Cost analysis of open and laparoscopic pancreaticoduodenectomy: a single institution comparison. Surg Endosc 2013;27:4518-23.PubMedCrossRefGoogle Scholar
  13. 13.
    Mechanic R, Tompkins C. Lessons learned preparing for Medicare bundled payments. N Engl J Med 2012;367:1873-5.PubMedCrossRefGoogle Scholar
  14. 14.
    Gagner M, Palermo M. Laparoscopic Whipple procedure: review of the literature. J Hepatobiliary Pancreat Surg 2009;16:726-30.PubMedCrossRefGoogle Scholar
  15. 15.
    Zenoni SA, Arnoletti JP, de la Fuente SG. Recent developments in surgery: minimally invasive approaches for patients requiring pancreaticoduodenectomy. JAMA Surg 2013;148:1154-7.PubMedCrossRefGoogle Scholar
  16. 16.
    Cirocchi R, Partelli S, Trastulli S, Coratti A, Parisi A, Falconi M. A systematic review on robotic pancreaticoduodenectomy. Surg Oncol 2013;22:238-46.PubMedCrossRefGoogle Scholar
  17. 17.
    Boggi U, Signori S, De Lio N, Perrone VG, Vistoli F, Belluomini M, Cappelli C, Amorese G, Mosca F. Feasibility of robotic pancreaticoduodenectomy. Br J Surg 2013;100:917-25.PubMedCrossRefGoogle Scholar
  18. 18.
    Enomoto LM, Gusani NJ, Dillon PW, Hollenbeak CS. Impact of Surgeon and Hospital Volume on Mortality, Length of Stay, and Cost of Pancreaticoduodenectomy. J Gastrointest Surg 2013;18:690-700.PubMedCrossRefGoogle Scholar
  19. 19.
    Shi HY, Wang SN, Lee KT. Temporal trends and volume-outcome associations in periampullary cancer patients: a propensity score-adjusted nationwide population-based study. Am J Surg 2013;207:512-9.PubMedCrossRefGoogle Scholar
  20. 20.
    Xie YB, Wang CF, Zhao DB, Shan Y, Bai XF, Sun YM, Chen YT, Zhao P, Tian YT. Risk factors associated with postoperative hospital stay after pancreaticoduodenectomy: a retrospective study. Chin Med J (Engl) 2013;126:3685-9.Google Scholar
  21. 21.
    Yoshioka R, Yasunaga H, Hasegawa K, Horiguchi H, Fushimi K, Aoki T, Sakamoto Y, Sugawara Y, Kokudo N. Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. Br J Surg 2014;101:523-9.PubMedCrossRefGoogle Scholar
  22. 22.
    Mohammed S, Fisher WE. Quality metrics in pancreatic surgery. Surg Clin North Am 2013;93:693-709.PubMedCrossRefGoogle Scholar
  23. 23.
    Veillette G, Dominguez I, Ferrone C, Thayer SP, McGrath D, Warshaw AL, Fernandez-del Castillo C. Implications and management of pancreatic fistulas following pancreaticoduodenectomy: the Massachusetts General Hospital experience. Arch Surg 2008;143:476-81.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula D. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13.PubMedCrossRefGoogle Scholar
  25. 25.
    Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.PubMedCrossRefGoogle Scholar
  26. 26.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.PubMedCrossRefGoogle Scholar
  27. 27.
    Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Buchler MW. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761-8.PubMedCrossRefGoogle Scholar
  28. 28.
    Nikfarjam M, Weinberg L, Low N, Fink MA, Muralidharan V, Houli N, Starkey G, Jones R, Christophi C. A fast track recovery program significantly reduces hospital length of stay following uncomplicated pancreaticoduodenectomy. JOP 2013;14:63-70.PubMedGoogle Scholar
  29. 29.
    Robertson N, Gallacher PJ, Peel N, Garden OJ, Duxbury M, Lassen K, Parks RW. Implementation of an enhanced recovery programme following pancreaticoduodenectomy. HPB (Oxford) 2012;14:700-8.CrossRefGoogle Scholar
  30. 30.
    Walters DM, McGarey P, LaPar DJ, Strong A, Good E, Adams RB, Bauer TW. A 6-day clinical pathway after a pancreaticoduodenectomy is feasible, safe and efficient. HPB (Oxford) 2013;15:668-73.CrossRefGoogle Scholar
  31. 31.
    Gawlas I, Sethi M, Winner M, Epelboym I, Lee J, Schrope B, Chabot J, Allendorf J. Readmission after pancreatic resection is not an appropriate measure of quality. Ann Surg Oncol 2013;20:1781-7.PubMedCrossRefGoogle Scholar
  32. 32.
    Kent T, Sachs T, Callery M, Vollmer CJ. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg 2011;213:515-23.PubMedCrossRefGoogle Scholar
  33. 33.
    Ahmad SA, Edwards MJ, Sutton JM, Grewal SS, Hanseman DJ, Maithel SK, Patel SH, Bentram DJ, Weber SM, Cho CS, Winslow ER, Scoggins CR, Martin RC, Kim HJ, Baker JJ, Merchant NB, Parikh AA, Kooby DA. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg 2012;256:529-37.PubMedCrossRefGoogle Scholar
  34. 34.
    Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PD. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford) 2013;16:350-6.CrossRefGoogle Scholar
  35. 35.
    Greenblatt DY, Kelly KJ, Rajamanickam V, Wan Y, Hanson T, Rettammel R, Winslow ER, Cho CS, Weber SM. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Ann Surg Oncol 2011;18:2126-35.PubMedCrossRefGoogle Scholar
  36. 36.
    Pecorelli N, Braga M, Doglioni C, Balzano G, Reni M, Cereda S, Albarello L, Castoldi R, Capretti G, Di Carlo V. Preoperative chemotherapy does not adversely affect pancreatic structure and short-term outcome after pancreatectomy. J Gastrointest Surg 2013;17:488-93.PubMedCrossRefGoogle Scholar
  37. 37.
    Amini A, Patanwala AE, Maegawa FB, Skrepnek GH, Jie T, Gruessner RW, Ong ES. Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. Am J Surg 2012;204:1000-4.PubMedCrossRefGoogle Scholar
  38. 38.
    Gilmore DM, Curran T, Gautam S, Nagle D, Poylin V. Timing is everything-colectomy performed on Monday decreases length of stay. Am J Surg 2013;206:340-5.PubMedCrossRefGoogle Scholar
  39. 39.
    Merkow RP, Bilimoria KY, Tomlinson JS, Paruch JL, Fleming JB, Talamonti MS, Ko CY, Bentrem DJ. Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer. Ann Surg 2013:Epub ahead of print.Google Scholar
  40. 40.
    Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P, Rawcliffe CL, Bassi C, Stocken DD, Cunningham D, O’Reilly D, Goldstein D, Robinson BA, Karapetis C, Scarfe A, Lacaine F, Sand J, Izbicki JR, Mayerle J, Dervenis C, Olah A, Butturini G, Lind PA, Middleton MR, Anthoney A, Sumpter K, Carter R, Buchler MW. Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study. J Clin Oncol 2014;32:504-12.PubMedCrossRefGoogle Scholar
  41. 41.
    Asbun HJ, Stauffer JA. Laparoscopic vs open pancreaticoduodenectomy: overall outcomes and severity of complications using the Accordion Severity Grading System. J Am Coll Surg 2012;215:810-9.PubMedCrossRefGoogle Scholar
  42. 42.
    Bao PQ, Mazirka PO, Watkins KT. Retrospective Comparison of Robot-Assisted Minimally Invasive Versus Open Pancreaticoduodenectomy for Periampullary Neoplasms. J Gastrointest Surg 2013;18:682-9.CrossRefGoogle Scholar
  43. 43.
    Correa-Gallego C, Dinkelspiel HE, Sulimanoff I, Fisher S, Vinuela EF, Kingham TP, Fong Y, DeMatteo RP, D’Angelica MI, Jarnagin WR, Allen PJ. Minimally-invasive vs open pancreaticoduodenectomy: systematic review and meta-analysis. J Am Coll Surg 2014;218:129-39.PubMedCrossRefGoogle Scholar
  44. 44.
    Croome KP, Farnell M, Que FG, Reid-Lombardo K, Truty M, Nagorney D, Kendrick ML. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Oncologic advantages over open approaches? Ann Surg 2014;In press.Google Scholar
  45. 45.
    Mesleh MG, Stauffer JA, Asbun HJ. Minimally invasive surgical techniques for pancreatic cancer: ready for prime time? J Hepatobiliary Pancreat Sci 2013:Epub ahead of print.Google Scholar
  46. 46.
    Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh HJ, 3rd. 250 robotic pancreatic resections: safety and feasibility. Ann Surg 2013;258:554`9.Google Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2014

Authors and Affiliations

  • Grace C. Lee
    • 1
  • Zhi Ven Fong
    • 1
  • Cristina R. Ferrone
    • 1
  • Sarah P. Thayer
    • 1
  • Andrew L. Warshaw
    • 1
  • Keith D. Lillemoe
    • 1
  • Carlos Fernández-del Castillo
    • 1
  1. 1.Department of SurgeryMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations